Skip to content

Common Carotid Artery-Renal Artery-Femoral Artery Survey for Hypertension

Common Carotid Artery-Renal Artery-Femoral Artery Survey for Hypertension (CRF Survey)

Status
Not yet recruiting
Phases
Unknown
Study type
Observational
Source
ClinicalTrials.gov
Registry ID
NCT07760623
Acronym
CRF Survey
Enrollment
100
Registered
2026-08-12
Start date
2026-08-01
Completion date
2027-05-18
Last updated
2026-08-12

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Hypertension, Hypertension (HTN), Artery Disease, Target Organ Damage

Keywords

hypertension, common carotid artery, renal artery, femmoral artery, vascular resistant

Brief summary

To evaluate both sides of the common carotid artery, renal artery, and femoral artery in Hypertension patient that cause of systemic arterial hypertension and/or the effects of target organ damage, both structural and functional markers.

Detailed description

The study of the first degree, both sides in some of the aortic branch group, the effect and/or cause of systemic arterial hypertension compared to normotension. According to the theory of systemic arterial hypertension, the arterial resistance and high blood volume flow causing systemic arterial hypertension, the cause of arterial resistance and high blood volume flow evaluation may trace back to the possible actual cause of systemic arterial hypertension by backward investigation. Despite the fact that target organ damage is the crucial maneuver of hypertension evaluation, both sides of the common carotid artery, renal artery, and femoral artery may cause systemic arterial hypertension and may imply that feasible to predict the end organ of stroke, ESRD, and amputated-type arterial occlusion, respectively. This study belongs to 2 questions 1. Can the main aortic branch be evidence of a cause of systemic arterial hypertension following high resistance and/or high fluid flow by theory? 2. Can the main aortic branch be a marker of evidence of endpoint organ damage?

Interventions

OTHERDiameter measurement

Radiographic diameter in cm. of each side of one of Common Carotid Artery, Renal Artery and Femoral Artery

Any kind of radiographic measurement of Peak Systolic Velocity and/or End Diastolic Velocity (cm/s)

Sponsors

DejthidaNathaphong
Lead SponsorOTHER

Study design

Observational model
COHORT
Time perspective
RETROSPECTIVE

Eligibility

Sex/Gender
ALL
Age
18 Years to No maximum
Healthy volunteers
No

Inclusion criteria

* Adults ≥18 years with diagnosed hypertension by a clinician, both untreated and treated, including successfully treated participants. * Imaging evidence of at least 1 list of * Common carotid artery * Renal artery * Femoral artery

Exclusion criteria

* Fatal pathology and imaging * Pediatric or pregnant participants * Small vessel angiogram * Intravascular endoscopy * Intra-operative estimation

Design outcomes

Primary

MeasureTime frameDescription
Median of diameter of common carotid artery, renal artery and femoral artery in hypertension patients.1 yearsRadiographic measurement includes ultrasonography, CT/MR imaging, and intravascular contrast media imaging that measure the diameter in cm. unit of any side of common carotid artery and/or renal artery and/or femoral artery in hypertension patients.

Secondary

MeasureTime frameDescription
Common Carotid Artery Function1 yearAny kind of radiographic measurement one of Peak Systolic Velocity (cm/s) or End Diastolic Velocity (cm/s) of any side of Common Carotid Artery
Renal Artery Function1 yearAny kind of radiographic measurement one of Peak Systolic Velocity (cm/s) or End Diastolic Velocity (cm/s) of any side of Renal Artery
Femoral Artery Function1 yearAny kind of radiographic measurement one of Peak Systolic Velocity (cm/s) or End Diastolic Velocity (cm/s) of any side of Femoral Artery

Countries

Thailand

Contacts

CONTACTNathaphong Dejthida, Medical Degree
bnnatto@gmail.com+66819220662

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Aug 13, 2026